Reporter July 26 2013
VU rolls out new business travel, expense system
Jul. 25, 2013—Vanderbilt’s ubiquitous green travel forms will go the way of eight-track tapes when the new travel system rolls out across the institution.
‘Bionic eye’ new option for retinitis pigmentosa patients
Jul. 25, 2013—Vanderbilt University Medical Center has been chosen as one of 12 sites in the United States to offer the first FDA-approved bionic eye for the treatment of retinitis pigmentosa (RP).
Pollen counts boost risk of rare drug reaction: study
Jul. 25, 2013—High pollen counts could trigger angioedema, a rare adverse reaction of Angiotension converting enzyme (ACE) inhibitors, Vanderbilt University researchers have found.
Visualizing data on network ‘maps’
Jul. 25, 2013—The new web application NetGestalt will allow investigators to simultaneously visualize different types of data for the same gene – such as mutation, expression and modification.
VU Stroke Center attains new level of certification
Jul. 24, 2013—The Vanderbilt Stroke and Cerebrovascular Service has received advanced certification as a Comprehensive Stroke Center by The Joint Commission and the American Heart Association/American Stroke Association, one of only four in Tennessee.
Vanderbilt to launch new flexible paid time off system for employees
Jul. 23, 2013—In order to more effectively meet the broadly diverse work/life needs across employees’ life phases, Vanderbilt is moving to a modernized benefits plan called flexPTO.
